Clinical trial
MyoSense- Automated Muscle Hypertonicity Classification System
NCT02076581 is registered in ClinicalTrials.gov with Great Lakes NeuroTechnologies Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MyoSense- Automated Muscle Hypertonicity Classification System
- Lead sponsor
- Great Lakes NeuroTechnologies Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2014
- Completion date
- April 30, 2015
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.